Resources Needed for Pediatric Preventive Cardiology Programs
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
FRIDAY, Aug. 11, 2023 -- Resources need to be invested in pediatric preventive cardiology programs, according to a scientific advisory published online Aug. 8 in Circulation: Cardiovascular Quality and Outcomes.
Noting that there is a lack of clarity on best practices to optimize and sustain desired outcomes for pediatric preventive cardiology programs, Amanda M. Perak, M.D., from Northwestern University in Chicago, and colleagues conducted surveys of pediatric cardiology division directors and pediatric preventive cardiology clinicians across the United States and Canada.
The authors found 47 percent of the respondents reported that their division had a dedicated preventive cardiology program, including in 65 percent of large pediatric cardiology divisions. Most respondents agreed that a dedicated program is a core part of the pediatric cardiology division, including 71 percent of large pediatric cardiology divisions. Most respondents agreed that preventive cardiology programs are valuable for public health, community, and improving clinical outcomes for patients and as an entry point for patients/families into the health system. The biggest challenges for the programs included lack of clinical resources, including physicians, dieticians, and clinical support; lack of interest or dedication from health care teams; financial sustainability; and lack of patient adherence. To improve the practice of pediatric preventive cardiology, the authors said updated guidelines, a registry study for outcomes, studies of novel care models in primary prevention, and advanced fellowship training programs are needed.
"Pediatric preventive cardiology services are in high demand but are underresourced and operating with limited guidance," the authors write. "We urge policymakers, payers, hospitals, heart centers, professional societies, foundations, and funders to match investments into pediatric preventive cardiology to the gravity and urgency of our youths' high burden of cardiovascular disease risk."
Several authors disclosed ties to the biopharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM
FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...
DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD
WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...
Statins Reduce CVD Risk in Adults Aged 75 to 85 and 85 Years and Older
TUESDAY, May 28, 2024 -- For patients aged 75 years and older, statin therapy is associated with a risk reduction in cardiovascular diseases (CVDs), according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.